FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Food and Drug Administration
About this archived opportunity
The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.
Historical details
- Status
- Closed
- Deadline
- January 30, 2026
- First captured
- January 13, 2026
- Publisher reference
- 344880
Eligibility: Foreign Institutions are not eligible to apply
This opportunity has closed
FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
by Food and Drug Administration
Get notified when similar opportunities open
We'll save this search and email you when new support, conferences, scientific opportunities are posted. Free.